Healthcare & Life Sciences: Drug Pricing Digest - September 2021 #2

Drug Pricing Initiatives: Democrats are continuing to debate the reconciliation package that contains many of President Biden’s domestic policy initiatives, including with respect to drug pricing. The budget reconciliation process allows passage in both chambers of Congress by a simple majority, but some Democratic Senators, including Joe Manchin of West Virginia and Kyrsten Sinema of Arizona, oppose the measure’s $3.5 trillion price tag. All 50 Democratic votes in the Senate would be needed for passage, with Vice President Kamala Harris casting the tie-breaking vote. A vote on the reconciliation package was scheduled for today, September 27, but whether the vote will proceed as scheduled is unclear.

Please see full Publication below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Latham & Watkins LLP | Attorney Advertising

Written by:

Latham & Watkins LLP
Contact
more
less

Latham & Watkins LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.